Abstract
[18F]MPPF is a selective and reversible antagonist to the serotonin‐1A (5‐HT1A) receptor. The aim of the present study was to investigate whether the binding of [18F]MPPF is sensitive to increases in 5‐HT levels. We used the 5‐HT releasing agent and reuptake inhibitor fenfluramine (FEN) to increase the concentration of 5‐HT. [18F]MPPF binding was assessed using positron emission tomography (PET) in conscious monkeys. Possible effects of blood flow on ligand binding were excluded by using a bolus‐infusion paradigm. Control scans were obtained to assess the state of ligand equilibrium. FEN (5 or 10 mg/kg, i.v.) was administered between 90 and 130 min after the start of the [18F]MPPF infusion. The binding potential (BP) was calculated for an early interval (30 min preceding FEN administration) and late interval (20–50 min after administration of FEN). Microdialyses results showed a 20‐ and 35‐fold increase in extracellular 5‐HT levels in the prefrontal cortex after injection of FEN at a dose of 5 mg/kg and 10 mg/kg respectively. However, despite these large increases in 5‐HT levels, no differences in BP were found between the control and FEN scans. These results may imply that the majority of 5‐HT1A receptors is in the low affinity state in the living brain. Synapse 59:18–26, 2006.

This publication has 52 references indexed in Scilit: